Xenon treatment protects against cold ischemia associated delayed graft function and prolongs graft survival in rats

American Journal of Transplantation

Volumn 13, Issue 8, 2013, Pages 2006-2018

  Zhao, H ^a   Watts, H R ^a   Chong, M ^a   Huang, H ^a   Tralau Stewart, C ^b   Maxwell, P H ^c   Maze, M ^d   George, A J T ^e   Ma, D ^a,f  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e HAMMERSMITH HOSPITAL   (United Kingdom)

^f HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Delayed graft function (DGF); graft survival; renal graft loss; treatment

Indexed keywords

CASPASE 3; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; XENON;

ANIMAL EXPERIMENT; ARTICLE; CELL STRUCTURE; CELL SURVIVAL; COLD ISCHEMIA; CONTROLLED STUDY; DELAYED GRAFT FUNCTION; GRAFT SURVIVAL; HUMAN; HUMAN CELL; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY;

DELAYED GRAFT FUNCTION (DGF); GRAFT SURVIVAL; RENAL GRAFT LOSS; TREATMENT;

ANESTHETICS, INHALATION; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; COLD ISCHEMIA; DELAYED GRAFT FUNCTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRAFT SURVIVAL; HMGB1 PROTEIN; HUMANS; HYPOTHERMIA; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOENZYME TECHNIQUES; KIDNEY; KIDNEY TRANSPLANTATION; NF-KAPPA B; RATS; RATS, INBRED F344; RATS, INBRED LEW; REPERFUSION INJURY; RNA, SMALL INTERFERING; TRANSPLANTATION, HOMOLOGOUS; XENON;

EID: 84881375174     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12293     Document Type: Article

References (35)

1. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B., Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378-383.
2. Li C, Yang CW., The pathogenesis and treatment of chronic allograft nephropathy. Nat Rev Nephrol 2009; 5: 513-519.
3. Quiroga I, McShane P, Koo DD, et al. Major effects of delayed graft function and cold ischaemia time on renal allograft survival. Nephrol Dial Transplant 2006; 21: 1689-1696.
4. Siedlecki A, Irish W, Brennan DC., Delayed graft function in the kidney transplant. Am J Transplant 2011; 11: 2279-2296.
5. Eltzschig HK, Eckle T., Ischemia and reperfusion-From mechanism to translation. Nat Med 2011; 17: 1391-1401.
6. Perico N, Cattaneo D, Sayegh MH, Remuzzi G., Delayed graft function in kidney transplantation. Lancet 2004; 364: 1814-1827.
7. Gluba A, Banach M, Hannam S, Mikhailidis DP, Sakowicz A, Rysz J., The role of Toll-like receptors in renal diseases. Nat Rev Nephrol 2010; 6: 224-235.
8. Lachmann B, Armbruster S, Schairer W, et al. Safety and efficacy of xenon in routine use as an inhalational anaesthetic. Lancet 1990; 335: 1413-1415.
9. Hartlage MA, Berendes E, Van Aken H, Fobker M, Theisen M, Weber TP., Xenon improves recovery from myocardial stunning in chronically instrumented dogs. Anesth Analg 2004; 99: 655-664, table of contents.
10. Preckel B, Mullenheim J, Moloschavij A, Thamer V, Schlack W., Xenon administration during early reperfusion reduces infarct size after regional ischemia in the rabbit heart in vivo. Anesth Analg 2000; 91: 1327-1332.
11. Ma D, Hossain M, Pettet GK, et al. Xenon preconditioning reduces brain damage from neonatal asphyxia in rats. J Cereb Blood Flow Metab 2006; 26: 199-208.
12. Ma D, Hossain M, Chow A, et al. Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann Neurol 2005; 58: 182-193.
13. Homi HM, Yokoo N, Ma D, et al. The neuroprotective effect of xenon administration during transient middle cerebral artery occlusion in mice. Anesthesiology 2003; 99: 876-881.
14. Ma D, Lim T, Xu J, et al. Xenon preconditioning protects against renal ischemic-reperfusion injury via HIF-1alpha activation. J Am Soc Nephrol 2009; 20: 713-720.
15. Li Q, Verma IM., NF-kappaB regulation in the immune system. Nat Rev Immunol 2002; 2: 725-734.
16. Hill P, Shukla D, Tran MG, et al. Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury. J Am Soc Nephrol 2008; 19: 39-46.
17. Bernhardt WM, Gottmann U, Doyon F, et al. Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model. Proc Natl Acad Sci USA 2009; 106: 21276-21281.
18. Sharples EJ, Thiemermann C, Yaqoob MM., Mechanisms of disease: Cell death in acute renal failure and emerging evidence for a protective role of erythropoietin. Nat Clin Pract Nephrol 2005; 1: 87-97.
19. Pugh CW, Ratcliffe PJ., Regulation of angiogenesis by hypoxia: Role of the HIF system. Nat Med 2003; 9: 677-684.
20. Blydt-Hansen TD, Katori M, Lassman C, et al. Gene transfer-induced local heme oxygenase-1 overexpression protects rat kidney transplants from ischemia/reperfusion injury. J Am Soc Nephrol 2003; 14: 745-754.
21. Ilmakunnas M, Tukiainen EM, Rouhiainen A, et al. High mobility group box 1 protein as a marker of hepatocellular injury in human liver transplantation. Liver Transpl 2008; 14: 1517-1525.
22. Kruger B, Krick S, Dhillon N, et al. Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci USA 2009; 106: 3390-3395.
23. Wu H, Ma J, Wang P, et al. HMGB1 contributes to kidney ischemia reperfusion injury. J Am Soc Nephrol 2010; 21: 1878-1890.
24. Wu H, Chen G, Wyburn KR, et al. TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 2007; 117: 2847-2859.
25. Yang H, Rivera Z, Jube S, et al. Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proc Natl Acad Sci USA 2010; 107: 12611-12616.
26. Salahudeen AK, Haider N, May W., Cold ischemia and the reduced long-term survival of cadaveric renal allografts. Kidney Int 2004; 65: 713-718.
27. van der Vliet JA, Warle MC, Cheung CL, Teerenstra S, Hoitsma AJ., Influence of prolonged cold ischemia in renal transplantation. Clin Transplant 2011; 25: E612-E616.
28. Helal I, Fick-Brosnahan GM, Reed-Gitomer B, Schrier RW., Glomerular hyperfiltration: Definitions, mechanisms and clinical implications. Nat Rev Nephrol 2012; 8: 293-300.
29. Mackenzie HS, Tullius SG, Heemann UW, et al. Nephron supply is a major determinant of long-term renal allograft outcome in rats. J Clin Invest 1994; 94: 2148-2152.
30. Burne-Taney MJ, Yokota N, Rabb H., Persistent renal and extrarenal immune changes after severe ischemic injury. Kidney Int 2005; 67: 1002-1009.
31. Lu CY, Penfield JG, Kielar ML, Vazquez MA, Jeyarajah DR., Hypothesis: Is renal allograft rejection initiated by the response to injury sustained during the transplant process ? Kidney Int 1999; 55: 2157-2168.
32. Zhang L, Huang H, Cheng J, et al. Pre-treatment with isoflurane ameliorates renal ischemic-reperfusion injury in mice. Life Sci 2011; 88: 1102-1107.
33. Hieber S, Huhn R, Hollmann MW, Weber NC, Preckel B., Hypoxia-inducible factor 1 and related gene products in anaesthetic-induced preconditioning. Eur J Anaesthesiol 2009; 26: 201-206.
34. Raphael J, Zuo Z, Abedat S, Beeri R, Gozal Y., Isoflurane preconditioning decreases myocardial infarction in rabbits via up-regulation of hypoxia inducible factor 1 that is mediated by mammalian target of rapamycin. Anesthesiology 2008; 108: 415-425.
35. Rawat S, Dingley J., Closed-circuit xenon delivery using a standard anesthesia workstation. Anesth Analg 2010; 110: 101-109.